Dr. Anindya Goswami accomplished his PhD degree in Biochemistry and Molecular Biology from Indian Institute of Chemical Biology (CSIR), India and pursued Post Doctoral work in Markey Cancer Center, Lexington, USA. He is currently holding a position of Assistant Director and Principal Scientist in Indian Institute of Integrative Medicine (CSIR), India. His current research interest includes “Regulation of metastatic suppressor proteins in EMT progression in breast and pancreatic cancers”. Dr. Goswami has contributed more than 40 peer reviewed publications and patent in the area of anti-cancer research and delivered plentiful presentations in both national as well as international platforms. He is deeply involved in the reviewing procedure of diverse scientific journals and presently serving as Editorial Member of the following journals: SM Vascular Medicine; Insights in Cancer Research; Austin Pancreatic Disorders; The Scientific Pages of Stem Cell Research.
Epithelial Mesenchymal Transition (EMT); Metastatic suppressors; miRNA200c and its role in EMT; Anti-metastatic molecules from natural products; Signal transduction; Desmoplasia in pancreatic cancer; Drug-Target interaction and molecular modeling.